Wuxi Biologics Biosafety Testing (Suzhou)
Wuxi Biologics Biosafety Testing (Suzhou) is recorded as a service provider in 2 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 2 of 2 trials · Latest update first
Phase 3, Two-stage, Randomized Study of ONC-392 Versus Docetaxel in Metastatic Non-Small Cell Lung Cancers that Progressed on PD-1/PD-L1 Inhibitors
Sponsor Oncoc4 Inc.
- Start (EU)
- Latest update
- Estimated end
Phase 3, Two-stage, Randomized Study of ONC-392 Versus Docetaxel in Metastatic Non-Small Cell Lung Cancers that Progressed on PD-1/PD-L1 Inhibitors (PRESERVE-003)
Sponsor Oncoc4 Inc.
- Start (EU)
- Not reported
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Wuxi Biologics Biosafety Testing (Suzhou)?
The 2026-10-09 snapshot links Wuxi Biologics Biosafety Testing (Suzhou) to 2 distinct CTIS trials. Recorded services include Establishment and storage of MCB and WCB. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Wuxi Biologics Biosafety Testing (Suzhou)?
The most frequently recorded therapeutic areas are Solid Tumor Oncology. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Wuxi Biologics Biosafety Testing (Suzhou) conducted?
The linked trials record locations in 5 countries, including Belgium, Germany, Spain, Italy, Netherlands. These are trial locations, not confirmed office locations or countries where Wuxi Biologics Biosafety Testing (Suzhou) delivered services.
What can this page tell me about Wuxi Biologics Biosafety Testing (Suzhou)'s trial experience?
Browse 2 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Wuxi Biologics Biosafety Testing (Suzhou). Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Wuxi Biologics Biosafety Testing (Suzhou) Co. Ltd.